Added value PDF Imprimer

 WHAT IS ERINHA’S ADDED VALUE? BENEFITS FOR ALL STAKEHOLDERS

  • Access for all stakeholders to BSL-4 laboratories’ complementary capacities, expertise and services
  • Access to high containment capacities to develop own research programmes
  • Developing collaborations with BSL-4 labs experts
  • Public health support tool for stakeholders without a BSL-4 facility: improving response to global public health threats
  • Mobilizing research funding
  • Raising the profile of European highcontainment research at the European and international levels
  • Fostering ambitious research programmes
  • Complementary facilities & critical mass of scientific expertise dedicated to the detection & study of highly pathogenic microorganisms
  • Ambitious research projects that cannot be performed in the framework of one laboratory
  • Hosting cost-effective large-scale research programmes which respond to Public health, Academia and Industry needs
  • Spreading best practices for biosafety & training
  • Operating with common basic training and biosafety standards
  • Broadening the knowledge base and staff exchanges

IN ADDITION, SEVERAL ADVANTAGES FOR DIFFERENT TYPES OF STAKEHOLDERS: 

For Member States with a national BSL-4 capacity:

  • Infrastructure improvement through shared investment
  • Additional scientific expertise and specific knowledge from other involved stakeholders
  • Continuous improvement through audit, review and capacity building

For Member States without a national BSL-4 capacity:

  • Access to high-containment facilities for development of own or collaborative research programmes
  • Visibility and acknowledgment of national research on the European and international levels
  • Support to face national public health challenges
  • Access to knowledge and expertise relevant for the operation of BSL-3 laboratories

For Europe:

  • Providing a world-leading high containment capacity to improve response to global public health threats
  • Boosting the European Research & Innovation competitiveness and scientific advancement
  • Optimization of the use of the High containment capacities in Europe
  • Encouraging collaboration, reducing duplication and developing synergies
  • Representing European interests in international expert groups and influencing strategic thinking